BACKGROUND Typically occurring on the external genitalia, anogenital warts (AGWs) are
benign epithelial skin lesions caused by human papillomavirus infection. AGWs are usually …

… the cost-effectiveness of podophyllotoxin and imiquimod in the treatment of anogenital warts
in … , so that the costs in the model comprised UK drug acquisition costs and NHS GUM clinic …

… . Clinical effectiveness and cost-effectiveness of interventions for the treatment of
anogenital warts: systematic review and economic evaluation. Health Technol Assess 2016;20:1–486.…

… No treatment hierarchy for external anogenital warts (AGW) is currently recommended,
despite wide variations in the costs of available treatments. The aim of this study was to propose …

… to utilise our results to compare the cost effectiveness of bivalent versus quadrivalent
HPV … . European Guidelines (IUSTI/WHO) on the management of anogenital warts. Poster …

… Availability and cost may also dictate choice of treatment, and cost effectiveness will vary …
2 laser therapy second line as the most cost effective from a UK perspective. Care providers are …

… The objective of this study was to evaluate the cost-effectiveness and treatment-cost
impact of sinecatechins as first-line therapy against its principal comparator, imiquimod in the …

… Background Anogenital warts (AGWs, condylomata acuminata) are among the most common
STIs … Anogenital warts are common STIs and may severely impact quality of life; treatment …

… results, 8 but in this article we present the cost of treatment data, estimate the period of
time … warts. These results were used to parameterize a recently published cost-effectiveness …

… ative efficacy, cost, and cost effectiveness of five common treatments for genital warts
were … We reviewed the clinical literature for tbe following genital wart therapies: podofilox, …